Retreatment with ¹⁷⁷Lu-DOTATATE after progression is well tolerated and offers disease control in patients with progressive NETs after initial treatment. ow.ly/A3Yc50R5LTz

#NuclearMedicine #RPTherapy #NETcancer

The current and future roles of precision oncology in advanced breast cancer: ow.ly/CmtU50QUp4H

#NuclearMedicine #PrecisionOncology #BreastCancer Heather Jacene

Sequencing of somatostatin-receptor–based therapies in neuroendocrine tumor patients. ow.ly/LjIu50QUoXG

#NuclearMedicine #RPTherapy #NETCancer @LisaBodei

Radioguided surgery accurately detects and removes metastatic lymph nodes in newly diagnosed #ProstateCancer patients: ow.ly/e44Z50QUoQ4

#NuclearMedicine #PSMA

Case Report: Pulmonary actinomyces infection mimics lung cancer on ⁶⁸Ga-FAPI PET/CT. ow.ly/mrHR50QUoES

#NuclearMedicine #PETscan #MedicalImaging prof. Stefano Fanti

Advancing neuroimaging: Julie Price talks with Henryk Barthel about enhanced understanding of the brain and neurodegeneration. ow.ly/KAgl50QUoq1

#NuclearMedicine #PETscan #Neuroimaging

The accomplishments and legacy of Saul Hertz, MD: ow.ly/ryG750QUon9

#NuclearMedicine #ThyroidCancer #Theranostics Michael Hofman

In #mCRPC patients treated with RLT and imaged with ¹⁸F-PSMA-1007, frameworks using both biochemical (PCWG3) and PET-based response (RECIP 1.0) may best assist in identifying subjects prone to disease progression. ow.ly/kPsX50QUoaK

#NuclearMedicine

Promising candidate prognostic biomarkers in ¹⁸F-FDG PET images: Evaluation in independent cohorts of non–small cell lung cancer patients. ow.ly/ez6m50QUo2A

#NuclearMedicine #NSCLC #MolecularImaging LITO Institut Curie Irène Buvat

JNM Illustrated Post: First-in-human ²¹²Pb-PSMA–targeted α-therapy SPECT/CT imaging in a patient with metastatic castration-resistant prostate cancer. ow.ly/1kt750QMSCL

#NuclearMedicine #RPTherapy #ProstateCancer Dave Pattison AdvanCell Isotopes

A new deep, semisupervised transfer learning approach for fully automated, whole-body tumor segmentation and prognosis on PET/CT: ow.ly/LnoK50QMStr

#NuclearMedicine #DeepLearning #PETscan @radnump

Single-time-point renal dosimetry using nonlinear mixed-effects modeling and population-based model selection in ¹⁷⁷Lu-PSMA-617 therapy. ow.ly/revl50QMSko

#NuclearMedicine #ProstateCancer #Dosimetry

Clinical evaluation of deep learning for tumor delineation on 18F-FDG PET/CT of #HeadandNeckCancer . ow.ly/pAtC50QHZNr

#NuclearMedicine #ArtificialIntelligence David Kovacs

MIRD Pamphlet No. 29: MIRDy90—A 90Y research microsphere dosimetry tool. ow.ly/mHae50QHZMg

#LiverCancer #RPTherapy #NuclearMedicine Memorial Sloan Kettering Cancer Center

uMI Panorama offers enhanced diagnostic capability for detecting small and low-contrast lesions while showing promising potential under high-count-rate imaging scenarios. ow.ly/Oveo50QHZIw

#NuclearMedicine #PETscan #MolecularImaging

The effectiveness of ²²⁵Ac-labeled anti-EGFR radioimmunoconjugate in EGFR-positive Kirsten rat sarcoma viral oncogene and BRAF mutant colorectal cancer models. ow.ly/wePj50QGt6X

#NuclearMedicine #ColorectalCancer #RPTherapy Humphrey Fonge

The potential contribution of radiopharmaceutical therapies in managing oligometastatic disease. ow.ly/J1IG50QGt5F

#ProstateCancer #NuclearMedicine #RPTherapy Amar Kishan UCLA Jonsson Comprehensive Cancer Center Jeremie Calais

The DETECT trial: Are we on the verge of precision surgery in primary prostate cancer? ow.ly/W3y250QGt4m

#NuclearMedicine #ProstateCancer #PETscan Boris Hadaschik

Molecular imaging of acute graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation has great potential to detect GvHD at the early stages. ow.ly/fi0R50QGiQm

#MolecularImaging #HSCT #NuclearMedicine Israt Alam

The need for objective task-based evaluation of image segmentation algorithms for quantitative PET. ow.ly/PL2450QGiOk

#NuclearMedicine #ArtificialIntelligence #MedicalImaging Abhinav Jha, Ph.D.